Momentum Clinical Research is thrilled to announce the opening of a new clinical research site in Pukekohe, South Auckland, set to launch this August. This expansion marks an exciting step for Momentum as we bring our leading clinical trial expertise to New Zealand’s largest city. With recruitment for study coordinators and investigators commencing soon, we are eager to build a strong local team dedicated to advancing medical research.

Momentum Clinical Research represents the merger of three respected names in clinical research—P3 Research in New Zealand, along with Holdsworth House and AusTrials in Australia—creating the largest fully integrated network of clinical trial sites across Australasia. Our network now spans New Zealand and Australia, with the name officially changing to Momentum Clinical Research on July 1, 2024.

With a network that covers phase Ib to IV clinical trials across a wide array of therapeutic areas, Momentum is well-positioned to provide sponsors and participants with unparalleled support and services. Our unique “one contract, multiple sites” model streamlines trial coordination, delivering faster, more efficient trial processes through seamless collaboration across locations.

Driven by our mission to provide people-centered research and clinical excellence at scale, we aim to make a meaningful impact on healthcare outcomes across Australasia. This new Pukekohe site strengthens our commitment to this mission, enabling us to expand our reach and support Auckland’s diverse community in clinical research.

As we prepare to launch, we look forward to welcoming highly skilled research staff to join the Momentum team in Pukekohe and contribute to our shared vision of pioneering medicines that enhance health outcomes across the region.